Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Monoclonal antibody humanness score and its applications.

Gao SH, Huang K, Tu H, Adler AS.

BMC Biotechnol. 2013 Jul 5;13:55. doi: 10.1186/1472-6750-13-55.

2.

The humanness of macaque antibody sequences.

Thullier P, Huish O, Pelat T, Martin AC.

J Mol Biol. 2010 Mar 12;396(5):1439-50. doi: 10.1016/j.jmb.2009.12.041.

PMID:
20043919
3.

Analyzing the "degree of humanness" of antibody sequences.

Abhinandan KR, Martin AC.

J Mol Biol. 2007 Jun 8;369(3):852-62.

PMID:
17442342
4.

A molecular immunology approach to antibody humanization and functional optimization.

Lazar GA, Desjarlais JR, Jacinto J, Karki S, Hammond PW.

Mol Immunol. 2007 Mar;44(8):1986-98.

PMID:
17079018
5.

Antibody humanization by structure-based computational protein design.

Choi Y, Hua C, Sentman CL, Ackerman ME, Bailey-Kellogg C.

MAbs. 2015;7(6):1045-57. doi: 10.1080/19420862.2015.1076600.

6.

Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies.

van Schouwenburg PA, Kruithof S, Votsmeier C, van Schie K, Hart MH, de Jong RN, van Buren EE, van Ham M, Aarden L, Wolbink G, Wouters D, Rispens T.

J Biol Chem. 2014 Dec 12;289(50):34482-8. doi: 10.1074/jbc.M114.615500. Review.

7.

Characterization of a novel humanized anti-CD20 antibody with potent anti-tumor activity against non-Hodgkin's lymphoma.

Zhang H, Song L, Ye H, Hu L, Liang W, Liu D.

Cell Physiol Biochem. 2013;32(3):645-54. doi: 10.1159/000354468.

8.

Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.

Carrasco-Triguero M, Yi JH, Dere R, Qiu ZJ, Lei C, Li Y, Mahood C, Wang B, Leipold D, Poon KA, Kaur S.

Bioanalysis. 2013 May;5(9):1007-23. doi: 10.4155/bio.13.64.

PMID:
23641693
9.

Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.

De Pascalis R, Iwahashi M, Tamura M, Padlan EA, Gonzales NR, Santos AD, Giuliano M, Schuck P, Schlom J, Kashmiri SV.

J Immunol. 2002 Sep 15;169(6):3076-84.

10.

Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody.

Covaceuszach S, Marinelli S, Krastanova I, Ugolini G, Pavone F, Lamba D, Cattaneo A.

PLoS One. 2012;7(3):e32212. doi: 10.1371/journal.pone.0032212.

11.

A proteomics approach for the identification and cloning of monoclonal antibodies from serum.

Cheung WC, Beausoleil SA, Zhang X, Sato S, Schieferl SM, Wieler JS, Beaudet JG, Ramenani RK, Popova L, Comb MJ, Rush J, Polakiewicz RD.

Nat Biotechnol. 2012 Mar 25;30(5):447-52. doi: 10.1038/nbt.2167.

PMID:
22446692
12.

Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies.

Kolbinger F, Saldanha J, Hardman N, Bendig MM.

Protein Eng. 1993 Nov;6(8):971-80.

PMID:
8309946
13.

Design of humanized antibodies: from anti-Tac to Zenapax.

Tsurushita N, Hinton PR, Kumar S.

Methods. 2005 May;36(1):69-83.

PMID:
15848076
14.

Humanized antibodies for antiviral therapy.

Co MS, Deschamps M, Whitley RJ, Queen C.

Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2869-73.

15.
18.
19.

Human monoclonal antibodies: the residual challenge of antibody immunogenicity.

Waldmann H.

Methods Mol Biol. 2014;1060:1-8. doi: 10.1007/978-1-62703-586-6_1. Review.

PMID:
24037833
20.

Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.

Baek DS, Kim YS.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):414-20. doi: 10.1016/j.bbrc.2015.05.086.

PMID:
26036575

Supplemental Content

Support Center